Rural patients are underrepresented in cancer clinical trials, yet there are many steps to increase rural cancer trial participation rates.

Provisions in the IRA intend to lower drug costs, yet unintended consequences to this goal will likely cost far more than the money saved.

After the COVID-19 pandemic, cancer clinical trials adopted a more patient-centric approach where trials work better for participants.